T\u00fcrkiye’de kanser \u00f6l\u00fcmleri 2020 y\u0131l\u0131 i\u00e7in 126 bin civar\u0131nda olup, 2040 y\u0131l\u0131nda bu rakam\u0131n 233 bine \u00e7\u0131kmas\u0131 \u00f6ng\u00f6r\u00fclmektedir.<\/p>\n
T\u00fcrk Kanser Ara\u015ft\u0131rma ve Sava\u015f Kurumu Derne\u011fi Genel Ba\u015fkan\u0131 Prof. Dr. Tezer Kutluk, \u201cSa\u011fl\u0131k Bakanl\u0131\u011f\u0131’n\u0131n 2018 y\u0131l\u0131 verilerine g\u00f6re T\u00fcrkiye’de ilk be\u015f s\u0131ray\u0131 erkeklerde akci\u011fer\/solunum yollar\u0131, prostat, kal\u0131n barsak, mesane, mide kanseri; kad\u0131nlarda meme, tiroid, kal\u0131n barsak, uterus, akci\u011fer\/solunum yollar\u0131 almaktad\u0131r. \u00c7ocuklarda ise her iki cins birlikte al\u0131nd\u0131\u011f\u0131nda ilk 5 s\u0131ray\u0131 l\u00f6semi, sinir sistemi t\u00fcm\u00f6rleri, lenfomalar, n\u00f6roblastoma ve yumu\u015fak doku sarkomlar\u0131 olu\u015fturmaktad\u0131r. Ayn\u0131 s\u0131ralama D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc’n\u00fcn 2020 y\u0131l\u0131 verilerine g\u00f6re de bildirilmektedir\u201d dedi.<\/p>\n
KANSER HER YA\u015eTA G\u00d6R\u00dcLEN IRK, C\u0130NS, \u00dcLKE AYRIMI G\u00d6ZETMEYEN B\u0130R HASTALIKTIR<\/strong><\/p>\n \u201cYa\u015f gruplar\u0131 hastal\u0131klara g\u00f6re de\u011fi\u015fmekle birlikte, kanser genel olarak 50’li ya\u015flardan sonra daha s\u0131k g\u00f6r\u00fclmektedir\u201d diyen Prof. Dr. Tezer Kutluk kanserin her ya\u015fta g\u00f6r\u00fclen, \u0131rk, cins, \u00fclke ayr\u0131m\u0131 g\u00f6zetmeyen bir hastal\u0131k oldu\u011funun alt\u0131n\u0131 \u00e7izdi ve \u00e7ocuklarda daha az g\u00f6r\u00fclmekle birlikte, yeni do\u011fan d\u00f6neminden ergenli\u011fe kadar her d\u00f6nemde kanser g\u00f6r\u00fcld\u00fc\u011f\u00fcn\u00fc belirtti.<\/p>\n Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 2018 y\u0131l\u0131 verilerine g\u00f6re 211.000 ki\u015finin kanser tan\u0131s\u0131 ald\u0131\u011f\u0131n\u0131 ifade eden Prof. Dr. Tezer Kutluk, d\u00fcnyada ve T\u00fcrkiye’de hastal\u0131klar aras\u0131nda kanserin ikinci \u00f6l\u00fcm nedeni oldu\u011funa dikkati \u00e7ekti.<\/p>\n Kanser \u00f6l\u00fcmlerinin d\u00fcnyada ve T\u00fcrkiye’de kalp damar hastal\u0131klar\u0131ndan sonra ikinci s\u0131ray\u0131 ald\u0131\u011f\u0131n\u0131 s\u00f6yleyen Prof. Dr. Kutluk, \u201cAncak ikinci s\u0131raya ra\u011fmen kanserden korunma, erken tan\u0131 ve etkin tedavi ile bu \u00f6l\u00fcmlerin 3-5 milyon kadar\u0131n\u0131 k\u0131sa ve orta vadede \u00f6nlemenin m\u00fcmk\u00fcn, her y\u0131l g\u00f6r\u00fclen 19 milyon yeni kanser vakas\u0131n\u0131n y\u00fczde 30-50’sinin \u00f6nlenebilir oldu\u011funu biliyoruz. B\u00fct\u00fcn bu say\u0131 ve oranlar bize korunma, tarama, erken tan\u0131 ve etkin tedavinin \u00f6nemini hat\u0131rlat\u0131yor\u201d diye konu\u015ftu.<\/p>\n \u0130yile\u015fme oranlar\u0131n\u0131n d\u00fcnya ortalamas\u0131n\u0131n y\u00fczde 42 oldu\u011funu ifade eden Prof. Dr. Tezer Kutluk, bu oranlar\u0131n \u00fcst gelir kategorisindeki \u00fclkelerde y\u00fczde 55 iken, d\u00fc\u015f\u00fck gelir kategorisindeki \u00fclkelerde y\u00fczde 20’lerin alt\u0131nda d\u00fc\u015ft\u00fc\u011f\u00fcne vurgu yapt\u0131.<\/p>\n BU BEL\u0130RT\u0130LERE D\u0130KKAT<\/strong><\/p>\n Kanser taramalar\u0131n\u0131n \u00f6zellikle 3 kanser t\u00fcr\u00fcnde toplum tabanl\u0131 olarak tavsiye edilmekte oldu\u011funu dile getiren Prof. Dr. Tezer Kutluk, kanser belirtilerini \u015f\u00f6yle s\u0131ralad\u0131:<\/p>\n Her y\u0131l g\u00f6r\u00fclen 19 milyon yeni kanser vakas\u0131n\u0131n y\u00fczde 30-50’sinin \u00f6nlenebilir oldu\u011funu, kanserle m\u00fccadelede en \u00f6nemli g\u00fcc\u00fcn erken te\u015fhis oldu\u011funun alt\u0131n\u0131 \u00e7izen T\u00fcrk Kanser Ara\u015ft\u0131rma ve Sava\u015f Kurumu Derne\u011fi Genel Ba\u015fkan\u0131 Prof. Dr. Tezer Kutluk, 4 \u015eubat D\u00fcnya Kanser G\u00fcn\u00fc vesilesiyle \u00f6nemli bilgiler payla\u015ft\u0131. \u0130STANBUL (\u0130GFA) – D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc (WHO) 2020 verilerine g\u00f6re T\u00fcrkiye’de …<\/p>\n","protected":false},"author":1,"featured_media":64134,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[13516,13514,13515,13521,13090,13001,13512,13002,13088,38,13003,12964,13518,13005,12785,13513,13520,13089,13006,13519,13517],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/kocaelikent.com\/wp-json\/wp\/v2\/posts\/64133"}],"collection":[{"href":"https:\/\/kocaelikent.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kocaelikent.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kocaelikent.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kocaelikent.com\/wp-json\/wp\/v2\/comments?post=64133"}],"version-history":[{"count":1,"href":"https:\/\/kocaelikent.com\/wp-json\/wp\/v2\/posts\/64133\/revisions"}],"predecessor-version":[{"id":64276,"href":"https:\/\/kocaelikent.com\/wp-json\/wp\/v2\/posts\/64133\/revisions\/64276"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kocaelikent.com\/wp-json\/wp\/v2\/media\/64134"}],"wp:attachment":[{"href":"https:\/\/kocaelikent.com\/wp-json\/wp\/v2\/media?parent=64133"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kocaelikent.com\/wp-json\/wp\/v2\/categories?post=64133"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kocaelikent.com\/wp-json\/wp\/v2\/tags?post=64133"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}![](\"https:\/\/www.igfhaber.com\/static\/pr\/prof-dr-tezer-kutluk-1675416156-245.jpg\")
<\/p>\n\n